Mylan N.V. (MYL) Given New $39.00 Price Target at Morgan Stanley
Mylan N.V. (NASDAQ:MYL) had its price objective increased by Morgan Stanley from $36.00 to $39.00 in a research report report published on Friday morning. Morgan Stanley currently has an equal weight rating on the stock.
A number of other equities research analysts have also weighed in on MYL. Royal Bank Of Canada reissued a hold rating and set a $41.00 price objective on shares of Mylan N.V. in a report on Tuesday, June 13th. ValuEngine lowered shares of Mylan N.V. from a buy rating to a hold rating in a report on Wednesday, June 14th. Cantor Fitzgerald started coverage on shares of Mylan N.V. in a report on Friday, June 16th. They set a neutral rating and a $41.00 price objective on the stock. BidaskClub raised shares of Mylan N.V. from a strong sell rating to a sell rating in a report on Friday, June 16th. Finally, Zacks Investment Research raised shares of Mylan N.V. from a sell rating to a hold rating in a report on Tuesday, August 1st. One research analyst has rated the stock with a sell rating, nine have given a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. Mylan N.V. currently has a consensus rating of Buy and a consensus target price of $41.99.
Shares of Mylan N.V. (MYL) traded up 0.98% during mid-day trading on Friday, reaching $38.29. The company’s stock had a trading volume of 6,284,973 shares. The firm’s 50 day moving average is $32.08 and its 200 day moving average is $36.45. The firm has a market cap of $20.53 billion, a PE ratio of 30.95 and a beta of 1.30. Mylan N.V. has a one year low of $29.39 and a one year high of $45.87. Mylan N.V. also was the recipient of some unusual options trading activity on Wednesday. Investors acquired 10,562 put options on the company. This is an increase of 461% compared to the typical daily volume of 1,883 put options.
Mylan N.V. (NASDAQ:MYL) last announced its quarterly earnings data on Wednesday, August 9th. The company reported $1.10 earnings per share for the quarter, missing analysts’ consensus estimates of $1.18 by ($0.08). The company had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $3 billion. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. Mylan N.V.’s quarterly revenue was up 15.7% compared to the same quarter last year. During the same period last year, the firm earned $1.16 earnings per share. On average, equities analysts anticipate that Mylan N.V. will post $4.57 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Mylan N.V. (MYL) Given New $39.00 Price Target at Morgan Stanley” was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at https://www.watchlistnews.com/mylan-n-v-myl-given-new-39-00-price-target-at-morgan-stanley/1616221.html.
Several hedge funds have recently bought and sold shares of the company. Bellwether Investment Group LLC boosted its stake in shares of Mylan N.V. by 0.3% during the 2nd quarter. Bellwether Investment Group LLC now owns 6,622 shares of the company’s stock worth $257,000 after acquiring an additional 23 shares in the last quarter. Suntrust Banks Inc. boosted its stake in shares of Mylan N.V. by 0.7% during the 2nd quarter. Suntrust Banks Inc. now owns 9,184 shares of the company’s stock worth $355,000 after acquiring an additional 60 shares in the last quarter. Cleararc Capital Inc. boosted its stake in shares of Mylan N.V. by 0.6% during the 1st quarter. Cleararc Capital Inc. now owns 10,394 shares of the company’s stock worth $405,000 after acquiring an additional 67 shares in the last quarter. Dai Ichi Life Insurance Company Ltd boosted its stake in shares of Mylan N.V. by 0.4% during the 2nd quarter. Dai Ichi Life Insurance Company Ltd now owns 26,002 shares of the company’s stock worth $1,009,000 after acquiring an additional 107 shares in the last quarter. Finally, Sei Investments Co. boosted its stake in shares of Mylan N.V. by 1.0% during the 1st quarter. Sei Investments Co. now owns 13,870 shares of the company’s stock worth $541,000 after acquiring an additional 134 shares in the last quarter. 71.97% of the stock is currently owned by institutional investors and hedge funds.
Mylan N.V. Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.